approval
saveLINZESS (LINACLOTIDE) — FDA approval
community read0 votes
Sponsor: ABBVIE. Form: CAPSULE. Route: ORAL
view source ↗Data sources
last refreshed 5mo ago
Found something off?
drug timeline · 8
- approvalLINZESS (LINACLOTIDE) — FDA approvalNov 4, 2025 · 336d ago
- approvalLINZESS (LINACLOTIDE) — FDA approvalJun 12, 2023 · 1212d ago
- approvalLINZESS (LINACLOTIDE) — FDA approvalAug 24, 2021 · 1869d ago
- approvalLINZESS (LINACLOTIDE) — FDA approvalApr 12, 2021 · 2003d ago
- approvalLINZESS (LINACLOTIDE) — FDA approvalSep 22, 2020 · 2205d ago
- approvalLINZESS (LINACLOTIDE) — FDA approvalMar 8, 2017 · 3499d ago
- approvalLINZESS (LINACLOTIDE) — FDA approvalJan 6, 2017 · 3560d ago
- approvalLINZESS (LINACLOTIDE) — FDA approvalAug 31, 2016 · 3688d ago
same company · ±60 days · 6
- approvalIMBRUVICA (IBRUTINIB) — FDA approvalJan 18, 2017
- approvallinaclotide: LINZESS (LINACLOTIDE) — FDA approvalJan 6, 2017
- approvalCARIPRAZINE HYDROCHLORIDE: VRAYLAR (CARIPRAZINE HYDROCHLORIDE) — FDA approvalFeb 23, 2017
- approvaldivalproex sodium DR: DEPAKOTE (DIVALPROEX SODIUM) — FDA approvalMar 6, 2017
- approvaldivalproex sodium DR: DEPAKOTE ER (DIVALPROEX SODIUM) — FDA approvalMar 6, 2017
- approvaldivalproex sodium DR: DEPAKOTE (DIVALPROEX SODIUM) — FDA approvalMar 6, 2017
comments(0)
5-min edit window · permanent after that